TMPRSS2 and prostate carcinoma: As a proof of concept, we further illustrated the usefulness of this model with a prostate cancer-specific gene fusion candidate TMPRSS2-ERG, re-discovered by next generation sequence analyses[26] (Additional files3 and4).